Kahar, Nasrin A.
HRN: 03-06-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2025
06/06/2025
IV
600mg
Q6
Fracture, Thumb, Right
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes